Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 28 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Sanofi India Ltd

About the Company - Sanofi India Ltd

Sanofi India Ltd. is a Public Limited Listed company incorporated on 02/05/1956 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1956PLC009794 and registration number is 009794. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2956.60 Cr. and Equity Capital is Rs. 23.00 Cr. for the Year ended 31/12/2021.
INDUSTRYADDRESSCONTACT
PharmaceuticalsSanofi House, CTS No. 117-B, Mumbai Maharashtra 400072igrc.sil@sanofi.com
http://www.sanofiindialtd.com
Management
NamePosition Held
Mr. Aditya NarayanChairman
Mr. Rodolfo HroszManaging Director
Mr. Cherian MathewWhole Time Director
Mr. Vaibhav KarandikarWholeTime Director & CFO
Mr. Charles BillardNon Executive Director
Mr. Marc Antoine LucchiniNon Executive Director
Ms. Usha ThoratIndependent Director
Mr. Rahul BhatnagarIndependent Director
Ms. Annapurna DasNon Executive Director

Sanofi India Ltd. Share Price Update

Share PriceValue
Today₹9,160.00
Previous Day₹9,212.40

Basic Stock Data of Sanofi India Ltd

Market Cap 20,647 Cr.
Current Price 8,965
High / Low9,380/5,330
Stock P/E35.0
Book Value 441
Dividend Yield2.17 %
ROCE71.1 %
ROE51.5 %
Face Value 10.0

Data Source: screener.in

Competitors of Sanofi India Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
IOL Chemicals & Pharmaceuticals Ltd 2,452 Cr. 418536/27214.2 2711.20 %13.7 %9.68 % 10.0
Aarti Pharmalabs Ltd 4,653 Cr. 513595/26924.0 1830.38 %16.1 %13.2 % 5.00
Solara Active Pharma Sciences Ltd 1,675 Cr. 465507/286 4070.00 %1.80 %1.44 % 10.0
Bafna Pharmaceuticals Ltd 213 Cr. 90.0126/77.018.9 34.80.00 %15.9 %16.4 % 10.0
J B Chemicals & Pharmaceuticals Ltd 25,542 Cr. 1,6461,940/87549.7 1750.54 %22.4 %17.6 % 1.00
Industry Average6,907.00 Cr626.4021.36214.160.42%13.98%11.66%7.20

Sanofi India Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales687720725789754688707699692672736706715
Expenses494553536542556561512538510505507528506
Operating Profit192167189247199127194161182167230178208
OPM %28%23%26%31%26%18%28%23%26%25%31%25%29%
Other Income1524261750416142161134441612
Interest0000000000010
Depreciation21202021141111111010101010
Profit before tax186170195243688132326166182190264183210
Tax %29%28%25%26%23%32%27%27%28%31%28%33%28%
Net Profit13312314617853090238120131131190123152
EPS in Rs57.7153.4163.3577.42230.0439.25103.5152.2856.8456.8482.6753.3666.09

Sanofi India Ltd Quarterly Chart

Sanofi India Ltd Profit & Loss

MonthDec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023
Sales1,5731,8091,9772,1932,3672,4602,7713,0712,9022,9572,7702,851
Expenses1,2611,4111,6391,8171,8321,9212,1462,4032,1862,1942,0662,047
Operating Profit312398339376535538625667716762704804
OPM %20%22%17%17%23%22%23%22%25%26%25%28%
Other Income4183131218667988334556420483
Interest100021102222
Depreciation90929711311910210310082674240
Profit before tax2623883734814805156106006771,258864846
Tax %32%32%29%33%37%37%38%31%29%25%28%29%
Net Profit177265264322304326381414478944621603
EPS in Rs76.71115.14114.46139.60132.09141.55165.26179.85207.38410.06269.47261.91
Dividend Payout %43%39%39%46%51%50%51%194%176%119%211%64%

Sanofi India Ltd Profit & Loss Yearly Chart

Sanofi India Ltd Growth

Compounded Sales Growth
10 Years:5%
5 Years:1%
3 Years:-1%
TTM:3%
Compounded Profit Growth
10 Years:9%
5 Years:9%
3 Years:5%
TTM:12%
Stock Price CAGR
10 Years:13%
5 Years:9%
3 Years:3%
1 Year:63%
Return on Equity
10 Years:22%
5 Years:27%
3 Years:33%
Last Year:52%

Sanofi India Ltd Balance Sheet

MonthDec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Jun 2023
Equity Capital23232323232323232323232323
Reserves1,0941,1811,3241,4631,6041,8602,0032,1962,4192,0962,2031,253701
Borrowings00000000023252420
Other Liabilities386427532742778658751765802777811772754
Total Liabilities1,5031,6311,8782,2282,4052,5412,7782,9843,2442,9183,0612,0721,498
Fixed Assets737699699648877817769733499464334306316
CWIP2343136210223430211710132410
Investments0000000000002
Other Assets7428881,0431,3691,5051,6901,9782,2302,7282,4442,7141,7431,170
Total Assets1,5031,6311,8782,2282,4052,5412,7782,9843,2442,9183,0612,0721,498

Sanofi India Ltd Reserves and Borrowings Chart

Sanofi India Ltd Cash Flow

MonthDec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022
Cash from Operating Activity 205290273265213322435374412611559399
Cash from Investing Activity -479-5-3356136-155-79-7366276631651
Cash from Financing Activity -147-90-105-122-147-180-188-197-183-810-849-1,583
Net Cash Flow-421195-168205102-1316810429578341-533

Sanofi India Ltd Financial Efficiency Indicators

MonthDec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022
Debtor Days292324212422292127191817
Inventory Days150135151179173169151154127107110125
Days Payable877583122817911911010093105109
Cash Conversion Cycle92839278115112616554332233
Working Capital Days2134326979171835-7-19-18
ROCE %27%23%29%22%26%27%26%29%28%32%35%41%

Sanofi India Ltd Financial Efficiency Indicators Chart

Sanofi India Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%
FIIs11.54%10.87%10.34%9.22%8.99%8.71%8.26%6.99%6.71%6.72%6.80%6.31%
DIIs17.18%17.41%17.67%19.05%18.65%18.59%18.28%19.22%19.46%19.65%21.68%20.83%
Public10.89%11.33%11.59%11.33%11.96%12.30%13.08%13.41%13.43%13.22%11.10%12.46%
No. of Shareholders48,46553,56751,64650,91659,27664,54273,73474,59376,69471,51368,59862,870

Sanofi India Ltd Shareholding Pattern Chart

No. of Sanofi India Ltd Shareholders

Sanofi India Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Aditya Birla Sun Life Frontline Equity Fund2685080.84216.62
Nippon India Pharma Fund2360082.94190.4
Nippon India Growth Fund2267660.78182.94
Nippon India Small Cap Fund1963420.36158.4
SBI Contra Fund1610000.68129.5
Nippon India Multi Cap Fund1523710.5122.93
SBI Long Term Equity Fund1479880.69119.04
Aditya Birla Sun Life Small Cap Fund1444332.22116.52
SBI Magnum Midcap Fund1008370.5681.11
Aditya Birla Sun Life Multi-Cap Fund873421.4370.46

Sanofi India Ltd ROCE Trend

Sanofi India Ltd EPS Trend

Sanofi India Ltd Key Financial Ratios

MonthDec 22Dec 21Dec 20Dec 19Dec 18
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)269.47410.06207.38179.85165.48
Diluted EPS (Rs.)269.47410.06207.38179.85165.48
Cash EPS (Rs.)288.04439.61243.39223.52210.13
Book Value[Excl.RevalReserv]/Share (Rs.)554.70967.65921.301061.87964.87
Book Value[Incl.RevalReserv]/Share (Rs.)554.70967.65921.301061.87964.87
Dividend / Share (Rs.)570.00490.00365.00349.0084.00
Revenue From Operations / Share (Rs.)1204.391285.481261.691335.041204.69
PBDIT / Share (Rs.)337.35363.87349.09330.17310.09
PBIT / Share (Rs.)319.13334.87313.35286.74265.43
PBT / Share (Rs.)375.78546.78294.43260.83265.13
Net Profit / Share (Rs.)269.83410.61207.65180.09165.48
PBDIT Margin (%)28.0028.3027.6624.7325.73
PBIT Margin (%)26.4926.0524.8321.4722.03
PBT Margin (%)31.2042.5323.3319.5322.00
Net Profit Margin (%)22.4031.9416.4513.4813.73
Return on Networth / Equity (%)48.6442.4322.5316.9517.15
Return on Capital Employeed (%)55.1433.3232.2925.9525.86
Return On Assets (%)29.9530.8516.3612.7612.75
Asset Turnover Ratio (%)1.080.980.940.980.96
Current Ratio (X)2.172.852.673.032.55
Quick Ratio (X)1.622.332.132.361.78
Inventory Turnover Ratio (X)1.371.461.411.811.78
Dividend Payout Ratio (NP) (%)253.4689.00168.2936.6942.98
Dividend Payout Ratio (CP) (%)237.4383.13143.5829.5633.85
Earning Retention Ratio (%)-153.4611.00-68.2963.3157.02
Cash Earning Retention Ratio (%)-137.4316.87-43.5870.4466.15
Interest Coverage Ratio (X)456.41464.94446.062531.331018.86
Interest Coverage Ratio (Post Tax) (X)288.41253.89289.501579.33544.71
Enterprise Value (Cr.)12437.3016603.6017922.4615006.2713779.31
EV / Net Operating Revenue (X)4.495.626.184.894.97
EV / EBITDA (X)16.0319.8422.3219.7619.32
MarketCap / Net Operating Revenue (X)4.866.146.595.255.27
Retention Ratios (%)-153.4610.99-68.2963.3057.01
Price / BV (X)10.558.169.036.616.58
Price / Net Operating Revenue (X)4.866.146.595.255.27
EarningsYield0.040.050.020.020.02

Sanofi India Ltd Profitability Ratios (%)

Sanofi India Ltd Liquidity Ratios

Sanofi India Ltd Liquidity Ratios (%)

Sanofi India Ltd Interest Coverage Ratios (X)

Sanofi India Ltd Valuation Ratios

Fair Value / Intrinsic Value of Sanofi India Ltd

Fair Value: ₹8121.52

The stock is overvalued by 9.41% compared to the current price ₹8965

*Investments are subject to market risks

Strength and Weakness of Sanofi India Ltd

StrengthWeakness
  1. The stock has a high average ROCE of 28.75%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 17.25, which is a positive sign.
  3. The company has higher reserves (1,645.92 cr) compared to borrowings (7.08 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (1.83 cr) and profit (508.08 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 338.11 and average Dividend Yield of 24.17%.
  2. The stock has a high average Cash Conversion Cycle of 70.00, which may not be favorable.

Should I Buy Sanofi India Ltd Share Now?

  • Considering various financial indicators, investors might exercise caution regarding investment in Sanofi India Ltd:
    1. Net Profit Margin: 22.40%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 55.14% (Industry Average ROCE: 15.26%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. Interest Coverage Ratio (Post Tax): 288.41
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    4. Quick Ratio: 1.62
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    5. ✓ Stock P/E: 36.5 (Industry average Stock P/E: 75.44)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    6. ✗ Total Debt / Equity: N/A
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis suggests exercising caution. It's advisable to conduct further research or consult with financial experts before considering any investment.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Sanofi India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE